Common Stock, Shares, Outstanding of Skye Bioscience, Inc. from 31 Oct 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Skye Bioscience, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Oct 2012 to 31 Dec 2025.
  • Skye Bioscience, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 33,378,139, a 7.8% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Skye Bioscience, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 33,378,139 +2,403,580 +7.8% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 30,989,046 +650,756 +2.1% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 30,988,108 +2,920,201 +10% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 30,974,559 +2,911,652 +10% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 30,974,559 +18,625,316 +151% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 30,338,290 +17,999,380 +146% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 28,067,907 -943,481,701 -97% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 28,062,907 -943,486,701 -97% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 12,349,243 +8,695,124 +238% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 12,338,910 -483,586,202 -98% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 971,549,608 +475,624,496 +96% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 971,549,608 +475,624,496 +96% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 3,654,119 -472,454,326 -99% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 495,925,112 +19,816,657 +4.2% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 495,925,112 +99,844,446 +25% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 495,925,112 +128,284,030 +35% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 476,108,445 +188,034,030 +65% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 476,108,455 +226,034,040 +90% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 396,080,666 +212,872,919 +116% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 367,641,082 +184,433,335 +101% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 288,074,415 +105,179,168 +58% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 250,074,415 +115,979,168 +86% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 183,207,747 +49,112,500 +37% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 183,207,747 +49,300,000 +37% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 182,895,247 +48,987,500 +37% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 134,095,247 +650,167 +0.49% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 134,095,247 +1,393,668 +1% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 133,907,747 +1,493,668 +1.1% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 133,907,747 +100,284,918 +298% 31 Dec 2018 10-K 23 Mar 2020 2019 FY
Q3 2018 133,445,080 +102,774,417 +335% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 132,701,579 +102,366,916 +337% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 132,414,079 +105,103,416 +385% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 33,622,829 +12,059,666 +56% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q3 2017 30,670,663 +10,757,500 +54% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 30,334,663 +10,421,500 +52% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 27,310,663 +7,397,500 +37% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 21,563,163 +1,660,000 +8.3% 31 Dec 2016 10-K 19 Mar 2018 2017 FY
Q3 2016 19,913,163 +1,835,000 +10% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 19,913,163 +3,647,500 +22% 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 19,913,163 +3,647,500 +22% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 19,903,163 +3,903,163 +24% 31 Dec 2015 10-K 10 Mar 2017 2016 FY
Q3 2015 18,078,163 +6,308,163 +54% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 16,265,663 +12,642,163 +349% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 16,265,663 +12,642,163 +349% 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 16,000,000 +8,230,000 +106% 31 Dec 2014 10-K 21 Mar 2016 2015 FY
Q3 2014 11,770,000 +8,146,500 +225% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 3,623,500 +476,000 +15% 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 3,623,500 +476,000 +15% 30 Apr 2014 10-Q 05 Jun 2014 2014 Q2
Q4 2013 7,770,000 31 Dec 2013 10-K 27 Mar 2015 2014 FY
Q3 2013 3,623,500 +1,096,000 +43% 31 Oct 2013 10-Q 15 Sep 2014 2014 Q3
Q2 2013 3,147,500 31 Jul 2013 10-Q 16 Sep 2013 2013 Q3
Q1 2013 3,147,500 30 Apr 2013 10-Q 27 Jun 2013 2013 Q2
Q3 2012 2,527,500 31 Oct 2012 10-K 27 Jan 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.